Silent expectant worship every Sunday from 10 to 11 a.m., 2nd Floor, Bennington Senior Center, 124 Pleasant St. Light snacks ...
"Shania f**king Twain" is celebrating her 60th birthday (Photos via Getty Images, Amazon) In the first of the two photos, Shania can be seen wearing a dazzling, shimmery blue suit with white heels and ...
Gilead Sciences' Kite Pharma has cut off a collaboration with Shoreline Biosciences, ending a research collaboration on off-the-shelf cell therapies that was valued at more than $2.3 billion. The deal ...
Gilead Sciences (NASDAQ:GILD) announced on Tuesday that the European Commission granted marketing authorization for its antiviral therapy lenacapavir as a twice-yearly option for the prevention of HIV ...
Gilead Sciences broke ground on its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters in California. This milestone ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Hannah Frye Hannah Frye is a writer covering beauty and style. As the ...
The European Commission (EC) has approved Gilead’s Yeytuo (lenacapavir) for the prevention of HIV infection, consolidating the injectable drug’s potential to become one of the company’s leading ...
Kite Pharma, a Gilead Sciences subsidiary, has entered into a binding agreement to acquire Interius BioTherapeutics—a privately held biotechnology firm—for $350 million in cash. The strategic ...
Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries – PEPFAR, Coordinated ...
US Plans to Bring Gilead HIV Drug to Market in High-Burden HIV Countries WASHINGTON (Reuters) -The U.S. State Department announced a plan on Thursday to bring Gilead Sciences Inc's drug lenacapavir to ...
WASHINGTON (Reuters) -The U.S. State Department announced a plan on Thursday to bring Gilead Sciences Inc's drug lenacapavir to market "at cost" in high-burden HIV countries in an effort to reach two ...
(Reuters) -Gilead Sciences said on Wednesday it has started work on a new pharmaceutical development and manufacturing hub at its headquarters in Foster City, California, as part of its planned $32 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback